Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Tyratech's head lice treatment in Walmart stores from March

Tyratech's head lice treatment in Walmart stores from March

Natural insecticide specialist TyraTech (LON:TYR) is to sell its new head lice treatment product Vamousse in Walmart stores in the US from the end of March.

Bruno Jactel, TyraTech’s chief executive, said it was the company’s most important milestone to date and would significantly raise the profile of TyraTech's brands.

"I am delighted to report that TyraTech's breakthrough technology and innovative products are capturing the attention of major retailers."

TyraTech estimates the US market for head lice control products is worth US$150mln a year.

Vamousse’s superior efficacy and safety strong should enable to make it penetration of this market, Jactel added, and the Walmart decision reinforced the company’s confidence it would meet market expectations for revenues in 2014.

TyraTech’s products are based on natural essential oils that act against pests but have no effect on humans.

Its products focus on personal care, which includes the head lice treatments, animal health and household, agricultural and garden insecticides.

View full TYR profile View Profile

TyraTech, Inc. Timeline

March 15 2018
September 12 2017
September 12 2017

Related Articles

Italian police
July 09 2018
Founded 12 years ago, its aim is to design a system to produce graphene in a “sustainable, simple and a scalable way”

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use